检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:官海莲 陈妮[2] GUAN Hailian;CHEN Ni(Department of Pharmacy,Hainan Geriatric Hospital,Haikou 571100,Hainan,China;Faculty of Pharmaceutical Sciences,the Second Affiliated Hospital of Hainan Medical College,Haikou 571100,Hainan,China)
机构地区:[1]海南省干部疗养院海南省老年病医院药剂科,海南海口571100 [2]海南医学院第二附属医院药学部,海南海口571100
出 处:《中南医学科学杂志》2020年第3期233-237,共5页Medical Science Journal of Central South China
摘 要:探讨清脑降压颗粒联合厄贝沙坦治疗老年原发性高血压并糖尿病患者临床疗效及安全性。将76例老年原发性高血压并糖尿病患者随机分为两组。对照组38例采用厄贝沙坦治疗,观察组38例采用清脑降压颗粒+厄贝沙坦治疗。治疗结果显示,治疗结束后实验组临床疗效(94.74%)显著高于对照组(76.32%)(P<0.05);观察组治疗后舒张压、收缩压、血清胆固醇(TC)、甘油三酯(TG)、低密度胆固醇(LDL-C)、同型半胱氨酸(Hcy)、B型脑钠肽(BNP)水平明显低于对照组,HDL-C水平明显高于对照组(P<0.05);两组患者治疗期间均未出现严重不良反应(P>0.05)。因此,在老年原发性高血压并糖尿病患者临床治疗中,清脑降压颗粒联合厄贝沙坦治疗在降压、降血脂、改善血清Hcy、BNP作用显著,且安全性较高,值得推荐。To explore the clinical efficacy and safety of Qingnaojiangya granule combined with irbesartan in the treatment of elderly patients with essential hypertension and diabetes.76 elderly patients with essential hypertension and diabetes were randomly divided into two groups.38 cases in the control group were treated with irbesartan,38 cases in the observation group were treated with Qingnaojiangya granule+irbesartan.The results showed that the clinical effect of the experimental group(94.74%)was significantly higher than that of the control group(76.32%)(P<0.05);the observation group had diastolic pressure,systolic pressure,serum cholesterol(TC),triglyceride(TG),low-density cholesterol(LDL-C),homocysteine(Hcy)after treatment.The levels of BNP and HDL-C in the two groups were significantly lower than those in the control group(P<0.05).Therefore,in the clinical treatment of elderly patients with essential hypertension and diabetes,Qingnaojiangya granule combined with irbesartan has significant effect on reducing blood pressure and blood lipid,improving serum Hcy and BNP,and has high safety,which is worth recommending.
关 键 词:糖尿病 原发性高血压 老年患者 清脑降压颗粒 厄贝沙坦 临床疗效
分 类 号:R544.11[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3